United Imaging Spotlights Molecular Imaging Showstoppers at SNMMI 2026

LOS ANGELES, May 31, 2026 /PRNewswire/ — United Imaging, a global innovator…

BLUETTI Launches EOFY Sale on Power Solutions with Up to 44% OFF

SYDNEY, June 1, 2026 /PRNewswire/ — Clean energy leader BLUETTI is unleashing…

HARMONi-6 Demonstrates Significant Overall Survival Benefit (HR=0.66): Ivonescimab Plus Chemotherapy Superior to PD-1 Plus Chemotherapy in First-Line sq-NSCLC Landmark Results to Be Presented at ASCO 2026 Plenary Session

CHICAGO, May 31, 2026 /PRNewswire/ — Akeso, Inc. (9926.HK) ("Akeso" or the…

Relief as Firmable locates 15,000 accounting decision-makers reported missing at leading global B2B data provider

Sydney-based sales team initiates platform support ticket after discovering significantly more contacts…

AI: Digital to Physical | BEYOND Expo 2026 Leads Transformative Global Direction of Tech

MACAO, May 31, 2026 /PRNewswire/ — The BEYOND Expo 2026 has shown what…

Golden Goblet Competition Lineup Announced: Spotlight on the 2026 Contenders

SHANGHAI, May 31, 2026 /PRNewswire/ — The 28th Shanghai International Film Festival…

Dizal Presents Positive NSCLC Data for Fourth-Generation EGFR TKI DZD6008 and Golidocitinib in Combination with Anti-PD-1 at ASCO 2026

Oral presentation of DZD6008 demonstrated strong and durable anti-tumor activity, excellent BBB-penetrant…

Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC Published in The Lancet

CHENGDU, China, May 31, 2026 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the…